Fidelity Biosciences, a leading venture capital investor in private biopharmaceutical and medical technology companies, is the sole investor in EnVivo.
Fidelity Biosciences is a division of Fidelity Investments, one of the world’s leading providers of financial services. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firm’s own capital since 1969. This provides the flexibility and capabilities of traditional venture capital firms while eliminating the additional pressures of fundraising. The result is a clear focus on building long-term value for Fidelity, its management partners, and co-investors.